Two recently concluded studies on Unigen’s joint health ingredient AmLexin™ have been published with particular recognition in scientific periodicals Nutrition and the Journal of Exercise Nutrition and Biochemistry. AmLexin™ is a patented botanical composition that contains a standardized blend of bioflavonoids from the heartwood of Acacia catechu and the root bark of Morus alba.
Significant clinical results indicate Unigen’s newest skin care ingredient, UP1307, is effective in promoting skin hydration, firmness, and elasticity, with associated improvement in cellulite appearance. In the recently concluded clinical trial, UP1307 resulted in visibly superior results compared to similar cellulite products…
TRITERPENOID SAPONINS FROM THE ROOTS OF GLYCYRRHIZA GLABRA
Qingyao Shou1, Ping Jiao1, Mei Hong1, Qi Jia1, Indra Prakash2*, Sangphyo Hong2, Bin Wang2, Gil Ma2, Allison Bechman2
1Unigen USA, 2121 South State St., Suite 400, Tacoma, WA 984052 The Coca-Cola Company, One Coca-Cola Plaza North West, Atlanta, GA 30313
Unigen’s next generation joint protection product AmLexin™ has been clinically proven to aggressively support exercise recovery and within 1 to 3 days reduce delayed onset of muscular soreness post-exercise in healthy adults…
Unigen’s superior regulatory and science teams are adding value to Canadian market joint care brands with the announcement of Health Canada’s approval of 3 day and 5 day fast acting health claims for Univestin®, Unigen’s premier joint health ingredient…
Unigen is partnering with China’s top tier Institute of Chinese Materia Medica to complete DNA barcoding of botanicals and marines in Unigen’s proprietary PhyoLogix™ collection…
Unigen, Inc. has published a study showing Univestin has no adverse effects on the Cardiovascular, Respiratory and Central Nervous Systems…
Unigen, Inc. continues to fulfill their mission to bring the best of nature to humankind with new ingredients offerings and more research.
Univestin® proprietary joint health ingredient debuts with new branding, logo, marketing materials all designed to promote the Univestin Triple Play: Accelerated Action, Lasting Comfort, Long-term Safety…
Unigen continues to add to the extensive body of research surrounding Univestin®, their innovative joint health ingredient, with new studies on the effects of the compound on reproduction in rats. Unigen performed 3 separate but related studies, labeled as Part-I through III. Each part addresses a different aspect of fertility, reproduction and development…
Unigen, Inc. announced today that Grant Bergstrom joined the company to help further expand the awareness and distribution of the firm’s scientifically proven ingredients.